Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

OPDC Theme 1

Our team

  • Michele Hu
    Michele Hu

    Professor of Clinical Neuroscience and Consultant Neurologist

Latest publications

Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.

Journal article

Kahl F. et al, (2026), Mov Disord

Clinical prognostic indicators in multiple system atrophy.

Journal article

Goh YY. et al, (2026), Brain

Towards automated joint detection in sleep studies: bridging clinical insight and artificial intelligence.

Journal article

Dorier A. et al, (2026), Sleep

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Journal article

Nielsen L-K. et al, (2026), Mov Disord

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Journal article

Arnaldi D. et al, (2026), Eur J Nucl Med Mol Imaging

Serum p-tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder.

Journal article

Yan S. et al, (2026), Ann Neurol, 99, 912 - 921

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Journal article

Zhang Z. et al, (2026), medRxiv

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing.

Journal article

Trubshaw M. et al, (2026), Prog Neurobiol, 257

Cholinergic degeneration in prodromal and early Parkinson's disease: a link to present and future disease states.

Journal article

Eisenstein T. et al, (2026), Brain, 149, 226 - 237

The North American Prodromal Synucleinopathy study: protocol for a multi-site, longitudinal, observational study of idiopathic/isolated rapid eye movement sleep behavior disorder.

Journal article

Lim MM. et al, (2026), Sleep Adv, 7

Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Journal article

Vijiaratnam N. et al, (2026), Brain Commun, 8

Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data.

Journal article

Aubourg T. et al, (2026), BMJ Neurol Open, 8

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale

Journal article

Fan Z. et al, (2026), Annals of Neurology

Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease

Journal article

Chiu SY. et al, (2026), Annals of Neurology

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Journal article

Abdi IY. et al, (2025), J Parkinsons Dis, 15, 1412 - 1430

Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease.

Journal article

Gunter KM. et al, (2025), NPJ Digit Med, 8

Biomarkers

Journal article

Mak E. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Global network and local vulnerabilities underlie brain atrophy across Parkinson's disease stages.

Journal article

Vo A. et al, (2025), Brain

Actigraphy-based detection of isolated REM sleep behavior disorder: multicenter validation across devices and populations.

Journal article

Zhou L. et al, (2025), NPJ Digit Med, 8

Estrogen-related receptor gene expression associates with sex differences in cortical atrophy in isolated REM sleep behavior disorder.

Journal article

Filiatrault M. et al, (2025), Nat Commun, 16